Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies-Reference-Cited by-同舟云学术

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

Published:2003-02-28 Issue:3 Volume:48 Page:728-731
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Triolo Giovanni,Ferrante Angelo,Ciccia Francesco,Accardo-Palumbo Antonina,Perino Antonino,Castelli Antonio,Giarratano Antonio,Licata Giuseppe

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference17 articles.

1. Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia

2. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions

3. Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

4. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specialized and niche therapies;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies;Obstetrics, Gynecology and Reproduction;2024-09-12

3. Effect of IVIG therapy on pregnant women with unexplained recurrent spontaneous abortion: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-08-14

4. Preeclampsia and the Antiphospholipid Syndrome;Biomedicines;2023-08-18

5. Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review;American Journal of Reproductive Immunology;2023-08-15